Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
antiviral drug |
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
gptkb:L01BB04
|
| gptkbp:brand |
gptkb:Leustatin
gptkb:Mavenclad |
| gptkbp:CASNumber |
gptkb:4291-63-8
|
| gptkbp:category |
antineoplastic agent
immunosuppressant |
| gptkbp:chemicalFormula |
C10H12ClN5O3
|
| gptkbp:discoveredBy |
gptkb:Dennis_A._Carson
|
| gptkbp:hasSMILES |
Clc1ncnc2c1ncn2[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O
|
| https://www.w3.org/2000/01/rdf-schema#label |
2-chloro-2'-deoxyadenosine
|
| gptkbp:mechanismOfAction |
purine analog antimetabolite
|
| gptkbp:molecularWeight |
285.68 g/mol
|
| gptkbp:otherName |
gptkb:cladribine
|
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
immunosuppression
infections myelosuppression |
| gptkbp:usedFor |
treatment of multiple sclerosis
treatment of hairy cell leukemia |
| gptkbp:bfsParent |
gptkb:cladribine
gptkb:2-chlorodeoxyadenosine |
| gptkbp:bfsLayer |
7
|